As of Sep 02
| +2.38 / +3.47%|
The 21 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 84.00, with a high estimate of 91.00 and a low estimate of 64.00. The median estimate represents a +18.21% increase from the last price of 71.06.
The current consensus among 26 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.